Kato, Takayrasu - Resultats de la cerca - Dipòsit Digital de Documents de la UAB

Cerca col·leccions:

Ordena'ls per:	Mostrar els resultats:	Format de visualizació:

Dipòsit Digital de Documents de la UAB	1 registres trobats	La cerca s'ha fet en 0.00 segons.

$Outcomes in Patients with FLT3-Mutated Relapsed/ Refractory Acute Myelogenous Leukemia Who Underwent Transplantation in the Phase 3 ADMIRAL Trial of Gilteritinib versus Salvage Chemotherapy$

10 p, 903.6 KB

Outcomes in Patients with FLT3-Mutated Relapsed/ Refractory Acute Myelogenous Leukemia Who Underwent Transplantation in the Phase 3 ADMIRAL Trial of Gilteritinib versus Salvage Chemotherapy / Perl, Alexander E. (University of Pennsylvania) ; Larson, Richard A (University of Chicago) ; Podoltsev, Nikolai A. (Yale School of Medicine) ; Strickland, Stephen (Vanderbilt-Ingram Cancer Center) ; Wang, Eunice S. (Roswell Park Comprehensive Cancer Center) ; Atallah, Ehab (Medical College of Wisconsin) ; Schiller, Gary J. (David Geffen School of Medicine at UCLA) ; Martinelli, Giovanni (IRCCS Istituto Scientifico Romagnolo per lo Studio dei Tumori "Dino Amadori" IRST S.r.l) ; Neubauer, Andreas (Universitätsklinikum Giessen und Marburg GmbH) ; Sierra, Jorge (Institut d'Investigació Biomèdica Sant Pau) ; Montesinos, Pau (Hospital Universitari i Politècnic La Fe (València)) ; Recher, Christian (Centre Hospitalier Universitaire de Toulouse. Institut Universitaire du Cancer de Toulouse Oncopole. Université de Toulouse 3 Paul Sabatier) ; Yoon, Sung-Soo (Seoul National University Hospital) ; Maeda, Yoshinobu (Okayama University Hospital) ; Hosono, Naoko (University of Fukui) ; Onozawa, Masahiro (Hokkaido University) ; Kato, Takayrasu (Department of Hematology. University of Tsukuba) ; Kim, Hee-Je (Catholic Hematology Hospital. College of Medicine. The Catholic University of Korea) ; Hasabou, Nahla (Astellas Pharma US. Inc.) ; Nuthethi, Rishita (Astellas Pharma US. Inc.) ; Tiu, Ramon (Astellas Pharma US. Inc.) ; Levis, Mark J. (Sidney Kimmel Comprehensive Cancer Center. Johns Hopkins University)
The fms-like tyrosine kinase 3 (FLT3) inhibitor gilteritinib improved the survival of patients with relapsed or refractory (R/R) FLT3-mutated acute myelogenous leukemia (AML) in the phase 3 ADMIRAL trial. [...]
2023 - DOI (Digital Object Identifier)

10.1016/j.jtct.2022.12.006
Transplantation and Cellular Therapy, Vol. 29 Núm. 4 (april 2023) , p. 265.e1-265.e10

Registre complet -

Vegeu també: autors amb noms similars
1	Kato, T
4	Kato, T.
1	Kato, Takaharu
1	Kato, Takayuki
2	Kato, Terufumi
1	Kato, Tomomichi
3	Kato, Tsuyoshi

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.